Literature DB >> 26363062

Stress kinases in the modulation of metabolism and energy balance.

Elisa Manieri1, Guadalupe Sabio2.   

Abstract

Obesity is a new global pandemic, with growing incidence and prevalence. This disease is associated with increased risk of several pathologies, including diabetes, cardiovascular diseases, and cancer. The mechanisms underlying obesity-associated metabolic changes are the focus of efforts to identify new therapies. Stress-activated protein kinases (SAPK), including cJun N-terminal kinases (JNKs) and p38, are required for cellular responses to metabolic stress and therefore might contribute to the pathogenesis of obesity. Tissue-specific knockout models support a cell-type-specific role for JNK isoforms, in particular JNK1, highlighting its importance in cell homeostasis and organ crosstalk. However, more efforts are needed to elucidate the specific roles of other JNK isoforms and p38 family members in metabolism and obesity. This review provides an overview of the role of SAPKs in the regulation of metabolism.
© 2015 Society for Endocrinology.

Entities:  

Keywords:  JNK; SAPK; adipose tissue; brain and signal transduction; metabolism; obesity; p38; stress

Mesh:

Substances:

Year:  2015        PMID: 26363062      PMCID: PMC5176079          DOI: 10.1530/JME-15-0146

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  97 in total

1.  Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury.

Authors:  Grisha Pirianov; Katarina G Brywe; Carina Mallard; A David Edwards; Richard A Flavell; Henrik Hagberg; Huseyin Mehmet
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-25       Impact factor: 6.200

Review 2.  MAPK signalling in cellular metabolism: stress or wellness?

Authors:  Helmuth Gehart; Susann Kumpf; Arne Ittner; Romeo Ricci
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

3.  Modulation of the JNK pathway in liver affects insulin resistance status.

Authors:  Yoshihisa Nakatani; Hideaki Kaneto; Dan Kawamori; Masahiro Hatazaki; Takeshi Miyatsuka; Taka-Aki Matsuoka; Yoshitaka Kajimoto; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

4.  Prevention of steatosis by hepatic JNK1.

Authors:  Guadalupe Sabio; Julie Cavanagh-Kyros; Hwi Jin Ko; Dae Young Jung; Susan Gray; John Y Jun; Tamera Barrett; Alfonso Mora; Jason K Kim; Roger J Davis
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

5.  Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

Authors:  Peter J Klover; Teresa A Zimmers; Leonidas G Koniaris; Robert A Mooney
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

Review 6.  CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.

Authors:  Merly C Vogt; Jens C Brüning
Journal:  Trends Endocrinol Metab       Date:  2012-12-19       Impact factor: 12.015

7.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

8.  JNK3 perpetuates metabolic stress induced by Aβ peptides.

Authors:  Sung Ok Yoon; Dong Ju Park; Jae Cheon Ryu; Hatice Gulcin Ozer; Chhavy Tep; Yong Jae Shin; Tae Hee Lim; Lucia Pastorino; Ajaya J Kunwar; James C Walton; Alan H Nagahara; Kun Ping Lu; Randy J Nelson; Mark H Tuszynski; Kun Huang
Journal:  Neuron       Date:  2012-09-06       Impact factor: 17.173

9.  Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways.

Authors:  Monica Imbernon; Daniel Beiroa; María J Vázquez; Donald A Morgan; Christelle Veyrat-Durebex; Begoña Porteiro; Adenis Díaz-Arteaga; Ana Senra; Silvia Busquets; Douglas A Velásquez; Omar Al-Massadi; Luis Varela; Marina Gándara; Francisco-Javier López-Soriano; Rosalía Gallego; Luisa M Seoane; Josep M Argiles; Miguel López; Roger J Davis; Guadalupe Sabio; Françoise Rohner-Jeanrenaud; Kamal Rahmouni; Carlos Dieguez; Ruben Nogueiras
Journal:  Gastroenterology       Date:  2012-11-06       Impact factor: 22.682

10.  Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice.

Authors:  Xinmei Zhang; Aimin Xu; Sookja K Chung; Justin H B Cresser; Gary Sweeney; Rachel L C Wong; Anning Lin; Karen S L Lam
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

View more
  33 in total

1.  Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.

Authors:  Ahmed Lawan; Kisuk Min; Lei Zhang; Alberto Canfran-Duque; Michael J Jurczak; Joao Paulo G Camporez; Yaohui Nie; Timothy P Gavin; Gerald I Shulman; Carlos Fernandez-Hernando; Anton M Bennett
Journal:  Diabetes       Date:  2018-01-09       Impact factor: 9.461

2.  The MST3/STK24 kinase mediates impaired fasting blood glucose after a high-fat diet.

Authors:  Cristina Iglesias; Ebel Floridia; Miriam Sartages; Begoña Porteiro; María Fraile; Ana Guerrero; Diana Santos; Juan Cuñarro; Sulay Tovar; Rubén Nogueiras; Celia M Pombo; Juan Zalvide
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

Review 3.  Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.

Authors:  Ahmed Lawan; Anton M Bennett
Journal:  Trends Endocrinol Metab       Date:  2017-11-08       Impact factor: 12.015

4.  Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.

Authors:  Jia Xin Yu; Amanda J Craig; Mary E Duffy; Carlos Villacorta-Martin; Verónica Miguela; Marina Ruiz de Galarreta; Alexander P Scopton; Lisa Silber; Andres Y Maldonado; Alexander Rialdi; Ernesto Guccione; Amaia Lujambio; Augusto Villanueva; Arvin C Dar
Journal:  Mol Cancer Ther       Date:  2019-06-18       Impact factor: 6.261

5.  Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease.

Authors:  Savanie Fernando; Jacob Sellers; Shauri Smith; Sarayu Bhogoju; Sadie Junkins; Morgan Welch; Orion Willoughby; Nabin Ghimire; Cassandra Secunda; Marina Barmanova; Sean C Kumer; Kisuk Min; Ahmed Lawan
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

6.  SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.

Authors:  Noelia Keiran; Victoria Ceperuelo-Mallafré; Enrique Calvo; Maria Isabel Hernández-Alvarez; Miriam Ejarque; Catalina Núñez-Roa; Daniel Horrillo; Elsa Maymó-Masip; M Mar Rodríguez; Rosa Fradera; Juan Vladimir de la Rosa; Rosa Jorba; Ana Megia; Antonio Zorzano; Gema Medina-Gómez; Carolina Serena; Antonio Castrillo; Joan Vendrell; Sonia Fernández-Veledo
Journal:  Nat Immunol       Date:  2019-04-08       Impact factor: 25.606

7.  Adverse Husbandry of Maraena Whitefish Directs the Immune System to Increase Mobilization of Myeloid Cells and Proinflammatory Responses.

Authors:  Tomáš Korytář; Mareen Nipkow; Simone Altmann; Tom Goldammer; Bernd Köllner; Alexander Rebl
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

Review 8.  Brain JNK and metabolic disease.

Authors:  Rubén Nogueiras; Guadalupe Sabio
Journal:  Diabetologia       Date:  2020-11-16       Impact factor: 10.122

9.  Beiging Modulates Inflammatory Adipogenesis in Salt-Treated and MEK6-Transfected Adipocytes.

Authors:  Songjoo Kang; Myoungsook Lee
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

Review 10.  Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.

Authors:  Jesús Burillo; Patricia Marqués; Beatriz Jiménez; Carlos González-Blanco; Manuel Benito; Carlos Guillén
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.